Endo International Ordinary Shares reported 1.65B in Market Capitalization for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 189.13B 34.55B
Adamas Pharmaceuticals ADMS:US 123.49M 6.97M
Aerie Pharmaceuticals AERI:US $ 632.47M 84.99M
Amarin AMRN:US 1.9B 278.02M
Ani Pharmaceuticals ANIP:US $ 446.88M 87.99M
Antares Pharma ATRS:US $ 691.14M 26.12M
Biodelivery Sciences International BDSI:US $ 394.37M 31.32M
Bristol Myers Squibb BMY:US $ 140.17B 3.93B
Coherus Biosciences CHRS:US $ 1.25B 58.57M
Eli Lilly And LLY:US $ 161.51B 19.93B
Endo International Ordinary Shares ENDP:US 1.65B 895.11M
Flexion Therapeutics FLXN:US $ 446.82M 122.28M
Heron Therapeutics HRTX:US $ 1.92B 576.48M
Horizon Pharma HZNP:US 16.14B 992.1M
Lannett LCI:US $ 257.57M 16.88M
Ligand Pharmaceuticals LGND:US $ 1.6B 66.72M
Merk MRK:US $ 206956.82M 2843.73M
Novartis NOVN:VX 206.37B 9.23B
Pacira Pharmaceuticals PCRX:US $ 2.6B 30.01M
Patterson Companies PDCO:US $ 3.09B 228.07M
Pfizer PFE:US $ 204662.24M 724.75M
Phibro Animal Health PAHC:US $ 785.61M 81.72M
Revance Therapeutics RVNC:US $ 1.96B 286.51M
Supernus Pharmaceuticals SUPN:US $ 1.33B 232.53M
Takeda 4502:JP 5897.04B 4.95B
Teva Pharmaceutical TEVA:IT 33.48B 487.13M
Xeris Pharmaceuticals Inc XERS:US $ 299.1M 58.13M
Zoetis ZTS:US $ 78.66B 82.14M